EVENTS | VIEW CALENDAR
MANCHESTER, U.K.—RTS Life Science, a worldwide supplier of automated sample management and drug delivery testing systems, is partnering with Hall Analytical Laboratories to provide analytical services and consultancy in the area of automation and inhaler testing.
Initially focused on inhaled drug delivery devices, the companies will share facilities, technology and resources to provide a range of services to help organizations improve efficiency in the development, adoption and use of automation.
According to Mark Fish, director of drug delivery automation for RTS Life Science, the company's experience of inhaler testing automation means it understands how devices work and appreciate factors that can introduce variability in analytical testing.
"We have proven experience validating automation systems in accordance with the latest regulatory guidance," Fish says. "By offering these services, customers will benefit from this knowledge and have new options to help improve laboratory efficiency."
Fish points out the combination of RTS Life Science's device testing expertise and automated inhaler testing technology with Hall Analytical Laboratories' analytical problem solving expertise and GxP accredited facilities offers clients confidence that their analytical and automation needs for inhaled product testing will be understood and approached with a refreshing new depth of insight.
As pharmaceutical companies continue to recognize both the financial and quality benefits of outsourcing specialized scientific applications, Susan Jones, marketing manager with RTS Life Science, points out that suppliers of such services need to able to respond in a positive and prompt manner.
"It is very doubtful that one service company has all of the expertise in-house to adequately meet the stringent requirements and hence one logical action is to form partnerships between companies with complimentary specialized skills," she says. "This partnership is then able to react to the individual needs of their clients."
Jones says that the RTS and Hall Analytical partnership in the area of inhalation testing is a prime example of such a partnership.
"RTS is a recognized leader in the manufacture of automation devices for the pharmaceutical industry, whilst Hall has been providing high quality analytical data to the same market for many years," she notes. "The logical combination of such skills and expertise gives pharmaceutical confidence that the problem can be resolved by experts who fully understand the issues and challenges and are capable in providing the necessary solutions and data quality required."
Services to be provided in consultation with clients include method development for both manual and automated applications; equipment and analytical validation services; performance qualification of automation systems; laboratory and analytical consultancy for OINDP products; canister content testing; plus emitted and delivered dose uniformity testing.
Malcolm Kimber, managing director of Hall Analytical Laboratories, points out that this collaboration will help his company continue its customer-oriented focus.
"This partnership with RTS allows us to offer a more comprehensive range of services for inhaled devices, building on our experience working with pharmaceutical clients and our excellent reputation for regulatory compliance and analytical problem solving," Kimber says.
Under the agreement, Jones also notes that RTS will produce the automated testing instrumentation while Hall will provide the analytical testing and validation for the devices that are being tested to each client's individual requirements. In effect a complete tailored solution.
"The success of the venture will be measured by the uptake of the technology and the associated analytical work," she notes.